DALLAS, June 18, 2013 (LifeSiteNews) – Embattled breast cancer awareness group Komen for the Cure has announced the selection of a new CEO, Judith A. Salerno.
Salerno currently serves as executive director and chief operating officer of the Institute of Medicine (IOM), a chief adviser to the Obama Administration regarding the implementation of Obamacare.
Under Salerno’s leadership, the IOM told the Obama Administration that insurance companies should be forced to pay for contraceptives, sterilizations and abortion-causing drugs for all women, without co-pays. That recommendation became the controversial HHS contraceptive mandate, which requires employers to provide such insurance plans for their female employees or face heavy fines, regardless of their religious objections.
Salerno, 61, is replacing Komen founder Nancy Brinker, who stepped down last August after a controversy involving abortion giant Planned Parenthood. Last year, the Komen Foundation briefly opted to withhold more than half-a-million dollars in annual funding from the nation's leading abortion provider on the grounds that Planned Parenthood does not perform mammograms.
Click “like” if you are PRO-LIFE!
Komen donations doubled in the days after cutting ties with Planned Parenthood. But after a well-orchestrated backlash from Planned Parenthood’s supporters that dominated national headlines for days, Brinker caved in to the pro-aborts’ pressure campaign and restored funding before stepping down from her leadership role.
The betrayal led pro-life advocates to call for a boycott. Komen spokesman Andrea Rader recently told USA Today that participation in the group’s famous “Race for the Cure” rallies have been on a “dramatic” decline ever since.
Earlier this month, Komen announced that half of its three-day races this year had been canceled due to poor response, a situation that Rader blamed in part on the Planned Parenthood controversy.
The cities where no one will run for a cure are Boston; Chicago; Cleveland; Phoenix; San Francisco; Tampa Bay; and Washington, D.C.